Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis-Reference-Cited by-同舟云学术

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

Published:2017-07 Issue:1 Volume:153 Page:49-52.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Saadoun David,Pol Stanislas,Ferfar Yasmina,Alric Laurent,Hezode Christophe,Si Ahmed Si Nafa,de Saint Martin Luc,Comarmond Cloé,Bouyer Anne Sophie,Musset Lucile,Poynard Thierry,Resche Rigon Matthieu,Cacoub Patrice

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. The cryoglobulinaemias

2. Cryoglobulinemia Vasculitis

3. Therapy for Hepatitis C Virus–Related Cryoglobulinemic Vasculitis

4. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients

5. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients;Diagnostics;2024-06-05

2. Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals;Journal of Hepatology;2024-06

3. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals;Pathogens;2024-04-19

4. Liver Disease–Associated Glomerulopathies;Advances in Kidney Disease and Health;2024-03

5. Self-reactive B cells traverse a perfect storm of somatic mutagenesis to cause a virus-induced autoimmune disease;2024-01-08